A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial. (Record no. 27590154)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02090 a2200577 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517174420.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201807s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1549-490X |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1634/theoncologist.2017-0066 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Ko, Andrew H |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20180723 |
245 00 - TITLE STATEMENT | |
Title | A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The oncologist |
Date of publication, distribution, etc. | 12 2017 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1427-e129 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Albumins |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Deoxycytidine |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease-Free Survival |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HSP27 Heat-Shock Proteins |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Kaplan-Meier Estimate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Oligonucleotides, Antisense |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Paclitaxel |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pancreatic Neoplasms |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prognosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gemcitabine |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Murphy, Patrick B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Peyton, James D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shipley, Dianna L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Al-Hazzouri, Ahmed |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rodriguez, Francisco A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Womack, Mark S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Xiong, Henry Q |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Waterhouse, David M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tempero, Margaret A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Guo, Shuangli |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lane, Cassie M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Earwood, Chris |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | DeBusk, Laura M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bendell, Johanna C |
773 0# - HOST ITEM ENTRY | |
Title | The oncologist |
Related parts | vol. 22 |
-- | no. 12 |
-- | p. 1427-e129 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1634/theoncologist.2017-0066">https://doi.org/10.1634/theoncologist.2017-0066</a> |
Public note | Available from publisher's website |
No items available.